Brankamp J, Eberhardt C, Landgräber S, von Knoch M, Saxler G, Löer F, Kurth A A
Klinik für Unfall- und Handchirurgie Uniklinikum Düsseldorf.
Z Orthop Ihre Grenzgeb. 2006 Mar-Apr;144(2):187-91. doi: 10.1055/s-2006-921432.
This study presents an overview of the general effects of bisphosphonates and in particular of their effects on different problems in joint arthroplasty.
First the chemical properties are described, then the biological effects. It is already known that bisphosphonates have effects on orthopaedic diseases and an increasing number of studies are investigating what effects can be achieved in joint arthroplasty with these substances.
The bisphosphonates group was derived from industrial pyrophosphate which is used to prevent calcification. Bisphosphonates inhibit bone mineralisation and resorption. Several direct and indirect mechanisms are responsible for these effects. The inhibition of bone resorption is used to benefit patients suffering from various diseases causing increased bone resorption. Treatment with bisphosphonates results in greater bone density and improved mechanical bone quality. Indications for this treatment include osteoporosis, tumour-associated osseo-destruction, fibrous dysplasia and Paget's disease. Recent studies have shown that osseo-integration of metal implants is accelerated and periprosthetic bone loss, which is caused by various different mechanisms during the lifetime of an implant, can be reduced.
Bisphosphonates have been an established element in the treatment of bone metabolic disorders for many years. Their use in joint arthroplasty could become increasingly important.
本研究概述了双膦酸盐的一般作用,尤其是它们对关节置换术中不同问题的影响。
首先描述其化学性质,然后阐述生物学效应。已知双膦酸盐对骨科疾病有作用,并且越来越多的研究正在探究这些物质在关节置换术中能产生何种效果。
双膦酸盐类源于用于预防钙化的工业焦磷酸盐。双膦酸盐抑制骨矿化和骨吸收。这些作用由多种直接和间接机制引起。抑制骨吸收可使患有各种导致骨吸收增加疾病的患者受益。使用双膦酸盐治疗可提高骨密度并改善骨的力学质量。这种治疗的适应症包括骨质疏松症、肿瘤相关的骨质破坏、骨纤维发育不良和佩吉特病。最近的研究表明,金属植入物的骨整合加速,并且在植入物使用期间由各种不同机制引起的假体周围骨丢失可以减少。
多年来,双膦酸盐一直是治疗骨代谢紊乱的既定药物。它们在关节置换术中的应用可能会变得越来越重要。